Lazzaro, Carlo http://orcid.org/0000-0003-4795-1834
Article History
Received: 23 July 2021
Accepted: 29 July 2021
First Online: 5 August 2021
Declarations
:
: Carlo Lazzaro has no conflicts of interest/competing interests with this Letter to the Editor. Outside this Letter to the Editor, in the past 3 years Carlo Lazzaro has received research grants, speaker or consultancy fees from AstraZeneca S.p.A,, Boehringer Ingelheim Italia S.p.A., CSL Behring S.p.A., Ferring S.p.A., Ipsen S.p.A., Roche S.p.A., Sanofi S.p.A., Santen GmbH, Shire S.p.A, Sobi S.p.A.
Free to read: This content has been made available to all.